Get Real Time Here
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Infinity Pharmaceuticals Stock (OTC:INFI), Quotes and News Summary
Infinity Pharmaceuticals Stock (OTC: INFI) stock price, news, charts, stock research, profile.
| Open0.022 | Close- |
| Vol / Avg.280.889K / 3.825M | Mkt Cap1.997M |
| Day Range0.021 - 0.025 | 52 Wk Range0.021 - 1.300 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.110 | 0.0100 | ||||
| REV | 583.000K | 583.000K | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Piper Sandler | Edward Tenthoff | Downgrades | OverweightNeutral | - | - | - |
| 2022-11-16 | B. Riley Securities | Kalpit Patel | Downgrades | BuyNeutral | Lowers | 3.00 | 1.50 |
| 2022-05-23 | Piper Sandler | Edward Tenthoff | Maintains | Overweight | Lowers | 4.00 | 3.00 |
| 2022-03-31 | Truist Securities | Robyn Karnauskas | Maintains | Buy | Lowers | 12.00 | 4.00 |
How do I buy Infinity Pharmaceuticals (INFI) stock?
You can purchase shares of Infinity Pharmaceuticals (OTCPK: INFI) through any online brokerage.
Who are Infinity Pharmaceuticals's (INFI) competitors?
There are no as such competitors for Infinity Pharmaceuticals.
What is the target price for Infinity Pharmaceuticals (INFI) stock?
The latest price target for Infinity Pharmaceuticals (OTCPK: INFI) was reported by Piper Sandler on Friday, February 24, 2023. The analyst firm set a price target for 0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Infinity Pharmaceuticals (INFI)?
The stock price for Infinity Pharmaceuticals (OTCPK: INFI) is $0.022 last updated Today at September 22, 2023 at 5:42 PM UTC.
Does Infinity Pharmaceuticals (INFI) pay a dividend?
There is no dividend information for Infinity Pharmaceuticals.
When is Infinity Pharmaceuticals (OTCPK:INFI) reporting earnings?
Infinity Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Infinity Pharmaceuticals (INFI) going to split?
There is no upcoming split for Infinity Pharmaceuticals.
What sector and industry does Infinity Pharmaceuticals (INFI) operate in?
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.